BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 26950046)

  • 1. Nerve growth factor does not seem to be a biomarker for neurogenic lower urinary tract dysfunction after spinal cord injury.
    Krebs J; Pavlicek D; Stoyanov J; Pannek J; Wöllner J
    Neurourol Urodyn; 2017 Mar; 36(3):659-662. PubMed ID: 26950046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurogenic lower urinary tract dysfunction (NLUTD) in patients with spinal cord injury: long-term urodynamic findings.
    Schöps TF; Schneider MP; Steffen F; Ineichen BV; Mehnert U; Kessler TM
    BJU Int; 2015 Apr; 115 Suppl 6():33-8. PubMed ID: 25891318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity and specificity of urinary and serum neurotrophins in the diagnosis of neurogenic detrusor overactivity in multiple sclerosis].
    Bazhenov IV; Filippova ES; Bazarnyi VV; Sazonov SV; Volkova LI; Zaitseva LN
    Urologiia; 2018 Jul; (3):44-48. PubMed ID: 30035417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical usefulness of ultrasound assessment of detrusor wall thickness in patients with neurogenic lower urinary tract dysfunction due to spinal cord injury: urodynamics made easy?
    Pannek J; Bartel P; Göcking K; Frotzler A
    World J Urol; 2013 Jun; 31(3):659-64. PubMed ID: 23073657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder.
    Yokoyama T; Kumon H; Nagai A
    Neurourol Urodyn; 2008; 27(5):417-20. PubMed ID: 17924444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of spinal cord tractography in detecting lesions following selective bladder afferent and efferent fibers injury: A novel method for induction of neurogenic lower urinary tract dysfunction in rabbit.
    Sadeghmousavi S; Soltani Khaboushan A; Jafarnezhad-Ansariha F; Nejad-Gashti R; Farsi M; Esmaeil-Pour R; Alijani M; Majidi Zolbin M; Niknejad H; Kajbafzadeh AM
    Neurourol Urodyn; 2022 Sep; 41(7):1539-1552. PubMed ID: 35842827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary nerve growth factor level in children with neurogenic bladder due to myelomeningocele.
    Korzeniecka-Kozerska A; Porowski T; Michaluk-Skutnik J; Wasilewska A; Płoński G
    Scand J Urol; 2013 Oct; 47(5):411-7. PubMed ID: 23301927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Course of neurogenic bladder dysfunction in patients with spinal cord injury under homeopathic treatment].
    Pannek J; Pannek-Rademacher S; Amsler F
    Urologe A; 2020 Sep; 59(9):1076-1081. PubMed ID: 32424576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder management in individuals with chronic neurogenic lower urinary tract dysfunction.
    Krebs J; Wöllner J; Pannek J
    Spinal Cord; 2016 Aug; 54(8):609-13. PubMed ID: 26554274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerve growth factor-dependent hyperexcitability of capsaicin-sensitive bladder afferent neurones in mice with spinal cord injury.
    Shimizu T; Majima T; Suzuki T; Shimizu N; Wada N; Kadekawa K; Takai S; Takaoka E; Kwon J; Kanai AJ; de Groat WC; Tyagi P; Saito M; Yoshimura N
    Exp Physiol; 2018 Jun; 103(6):896-904. PubMed ID: 29603450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urodynamic effect of vibegron on neurogenic lower urinary tract dysfunction in individuals with spinal cord injury: A retrospective study.
    Matsuda K; Teruya K; Uemura O
    Spinal Cord; 2022 Aug; 60(8):716-721. PubMed ID: 35177800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuro-urological diagnosis and therapy of lower urinary tract dysfunction in patients with spinal cord injury : S2k Guideline of the German-Speaking Medical Society of Paraplegia (DMGP), AWMF register no. 179/001].
    Böthig R; Domurath B; Kaufmann A; Bremer J; Vance W; Kurze I
    Urologe A; 2017 Jun; 56(6):785-792. PubMed ID: 28314966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TASCI-transcutaneous tibial nerve stimulation in patients with acute spinal cord injury to prevent neurogenic detrusor overactivity: protocol for a nationwide, randomised, sham-controlled, double-blind clinical trial.
    Birkhäuser V; Liechti MD; Anderson CE; Bachmann LM; Baumann S; Baumberger M; Birder LA; Botter SM; Büeler S; Cruz CD; David G; Freund P; Friedl S; Gross O; Hund-Georgiadis M; Husmann K; Jordan X; Koschorke M; Leitner L; Luca E; Mehnert U; Möhr S; Mohammadzada F; Monastyrskaya K; Pfender N; Pohl D; Sadri H; Sartori AM; Schubert M; Sprengel K; Stalder SA; Stoyanov J; Stress C; Tatu A; Tawadros C; van der Lely S; Wöllner J; Zubler V; Curt A; Pannek J; Brinkhof MWG; Kessler TM
    BMJ Open; 2020 Aug; 10(8):e039164. PubMed ID: 32792454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder-emptying methods, neurogenic lower urinary tract dysfunction and impact on quality of life in people with long-term spinal cord injury.
    Adriaansen JJ; van Asbeck FW; Tepper M; Faber WX; Visser-Meily JM; de Kort LM; Post MW
    J Spinal Cord Med; 2017 Jan; 40(1):43-53. PubMed ID: 26446581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of intradetrusor botulinum toxin A injections on serum and urinary concentrations of nerve growth factor and brain-derived neurotrophic factor in patients with multiple sclerosis and neurogenic detrusor overactivity.
    Philippova ES; Bazhenov IV; Ziryanov AV; Bazarny VV
    Neurourol Urodyn; 2021 Jan; 40(1):95-101. PubMed ID: 33034916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional outcome of supratrigonal cystectomy and augmentation ileocystoplasty in adult patients with refractory neurogenic lower urinary tract dysfunction.
    Krebs J; Bartel P; Pannek J
    Neurourol Urodyn; 2016 Feb; 35(2):260-6. PubMed ID: 25524480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow development of bladder malfunction parallels spinal cord fiber sprouting and interneurons' loss after spinal cord transection.
    Sartori AM; Hofer AS; Scheuber MI; Rust R; Kessler TM; Schwab ME
    Exp Neurol; 2022 Feb; 348():113937. PubMed ID: 34826427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve growth factor combined with vascular endothelial growth factor enhances regeneration of bladder acellular matrix graft in spinal cord injury-induced neurogenic rat bladder.
    Kikuno N; Kawamoto K; Hirata H; Vejdani K; Kawakami K; Fandel T; Nunes L; Urakami S; Shiina H; Igawa M; Tanagho E; Dahiya R
    BJU Int; 2009 May; 103(10):1424-8. PubMed ID: 18990142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of spinal cord injury patients with neurogenic lower urinary tract dysfunction using minimally invasive and surgical therapies in Taiwan.
    Chen SF; Kuo HC
    Int Urol Nephrol; 2024 Apr; 56(4):1205-1216. PubMed ID: 38036803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Nogo-A Antibodies As a Potential Causal Therapy for Lower Urinary Tract Dysfunction after Spinal Cord Injury.
    Schneider MP; Sartori AM; Ineichen BV; Moors S; Engmann AK; Hofer AS; Weinmann O; Kessler TM; Schwab ME
    J Neurosci; 2019 May; 39(21):4066-4076. PubMed ID: 30902870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.